VanEck Pharmaceutical ETF
PPH
PPH
147 hedge funds and large institutions have $789M invested in VanEck Pharmaceutical ETF in 2026 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 41 increasing their positions, 41 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% less capital invested
Capital invested by funds: $806M → $789M (-$17.3M)
7.8% less ownership
Funds ownership: 68.62% → 60.82% (-7.8%)
95% less call options, than puts
Call options by funds: $603K | Put options by funds: $11M
Holders
147
Holding in Top 10
2
Calls
$603K
Puts
$11M
Top Buyers
| 1 | +$86.4M | |
| 2 | +$56.6M | |
| 3 | +$34.4M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$31.5M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$26.5M |
Top Sellers
| 1 | -$118M | |
| 2 | -$53.2M | |
| 3 | -$50M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$42.1M |
| 5 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
-$33.5M |
